267 related articles for article (PubMed ID: 10342414)
1. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.
Galer BS; Rowbotham MC; Perander J; Friedman E
Pain; 1999 Apr; 80(3):533-538. PubMed ID: 10342414
[TBL] [Abstract][Full Text] [Related]
2. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia.
Rowbotham MC; Davies PS; Verkempinck C; Galer BS
Pain; 1996 Apr; 65(1):39-44. PubMed ID: 8826488
[TBL] [Abstract][Full Text] [Related]
3. Topical lidocaine gel relieves postherpetic neuralgia.
Rowbotham MC; Davies PS; Fields HL
Ann Neurol; 1995 Feb; 37(2):246-53. PubMed ID: 7847866
[TBL] [Abstract][Full Text] [Related]
4. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.
Davies PS; Galer BS
Drugs; 2004; 64(9):937-47. PubMed ID: 15101784
[TBL] [Abstract][Full Text] [Related]
5. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
[TBL] [Abstract][Full Text] [Related]
6. Lidocaine patch 5%.
Comer AM; Lamb HM
Drugs; 2000 Feb; 59(2):245-9; discussion 250-1. PubMed ID: 10730547
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
[TBL] [Abstract][Full Text] [Related]
8. Topical lidocaine for the treatment of postherpetic neuralgia.
Khaliq W; Alam S; Puri N
Cochrane Database Syst Rev; 2007 Apr; (2):CD004846. PubMed ID: 17443559
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
10. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.
Galer BS; Jensen MP; Ma T; Davies PS; Rowbotham MC
Clin J Pain; 2002; 18(5):297-301. PubMed ID: 12218500
[TBL] [Abstract][Full Text] [Related]
11. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a double-blind and vehicle-controlled study.
Lin PL; Fan SZ; Huang CH; Huang HH; Tsai MC; Lin CJ; Sun WZ
Reg Anesth Pain Med; 2008; 33(4):320-5. PubMed ID: 18675742
[TBL] [Abstract][Full Text] [Related]
12. [Lidocaine tape (Penles--a dressing tape based on 60% lidocaine--) reduces the pain of postherpetic neuralgia].
Tamakawa S; Ogawa H
Masui; 1998 Jul; 47(7):882-4. PubMed ID: 9720343
[TBL] [Abstract][Full Text] [Related]
13. Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin.
Wasner G; Kleinert A; Binder A; Schattschneider J; Baron R
J Neurol; 2005 Jun; 252(6):677-86. PubMed ID: 15778907
[TBL] [Abstract][Full Text] [Related]
14. Topical acetylsalicylic acid versus lidocaine for postherpetic neuralgia: results of a double-blind comparative clinical trial.
Tajti J; Szok D; Vécsei L
Neurobiology (Bp); 1999; 7(2):103-8. PubMed ID: 10591045
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study.
Meier T; Wasner G; Faust M; Kuntzer T; Ochsner F; Hueppe M; Bogousslavsky J; Baron R
Pain; 2003 Nov; 106(1-2):151-8. PubMed ID: 14581122
[TBL] [Abstract][Full Text] [Related]
16. Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia.
Kanai A; Okamoto T; Suzuki K; Niki Y; Okamoto H
Anesth Analg; 2010 May; 110(5):1457-60. PubMed ID: 20237042
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
[TBL] [Abstract][Full Text] [Related]
18. [Reduction of chronic pain for non-postherpetic peripheral neuropathies after topical treatment with a lidocaine patch].
Meier T; Faust M; Hüppe M; Schmucker P
Schmerz; 2004 Jun; 18(3):172-8. PubMed ID: 15221421
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the depth and duration of anesthesia from heated lidocaine/tetracaine (Synera) patches compared with placebo patches applied to healthy adult volunteers.
Wallace MS; Kopecky EA; Ma T; Brophy F; Campbell JC
Reg Anesth Pain Med; 2010; 35(6):507-13. PubMed ID: 20975464
[TBL] [Abstract][Full Text] [Related]
20. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB).
Cheville AL; Sloan JA; Northfelt DW; Jillella AP; Wong GY; Bearden Iii JD; Liu H; Schaefer PL; Marchello BT; Christensen BJ; Loprinzi CL
Support Care Cancer; 2009 Apr; 17(4):451-60. PubMed ID: 19142669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
